|
|
|
R E S O L U T I O N
|
|
WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking |
|
place on February 22, 2023, and this occasion provides a fitting |
|
opportunity to promote better understanding of this health issue; |
|
and |
|
WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic |
|
cardiovascular disease that involves thickening of the heart muscle |
|
and can potentially lead to debilitating symptoms and serious |
|
complications, including heart failure, atrial fibrillation, |
|
stroke, and in rare cases, sudden cardiac death; and |
|
WHEREAS, HCM is the most common inheritable heart disease; it |
|
can affect anyone, regardless of age, gender, or ethnicity, and it |
|
has a reported prevalence ranging from 1 in 200 individuals to 1 in |
|
500 individuals in the general population; an estimated 58,722 to |
|
146,804 people in Texas have HCM, although approximately 85 percent |
|
of them remain undiagnosed; and |
|
WHEREAS, HCM shares symptoms with other common |
|
cardiovascular and pulmonary diseases, such as shortness of breath, |
|
chest pain, fatigue, palpitations, and fainting, and those |
|
similarities make it difficult to accurately diagnose HCM; in |
|
addition, the all-cause mortality risk is three to four times |
|
higher in patients with HCM than that of the general population; in |
|
order to receive a diagnosis, patients should know their medical |
|
history and stay informed about the signs and symptoms of HCM; and |
|
WHEREAS, Health care providers must conduct thorough |
|
screenings with cardiac health questions to help identify a risk of |
|
both genetic and congenital cardiac disorders; they may also |
|
conduct several tests, including an echocardiogram, a cardiac MRI, |
|
or genetic testing to confirm a family history of HCM, and they must |
|
examine the heart to diagnose HCM; and |
|
WHEREAS, Following a diagnosis of HCM, it is important for |
|
patients to work with their health care providers to learn more |
|
about the disease and different management options, such as |
|
prescription medicines and surgical treatments; and |
|
WHEREAS, Hypertrophic cardiomyopathy is a serious and |
|
life-threatening disease, and the observance of Hypertrophic |
|
Cardiomyopathy Awareness Day unites people around the world in |
|
their commitment to improving the quality of life for patients; |
|
now, therefore, be it |
|
RESOLVED, That the House of Representatives of the 88th Texas |
|
Legislature hereby recognize February 22, 2023, as Hypertrophic |
|
Cardiomyopathy Awareness Day and urge all Texans to learn more |
|
about the disease; and, be it further |
|
RESOLVED, That an official copy of this resolution be |
|
prepared for the Hypertrophic Cardiomyopathy Association as an |
|
expression of high regard by the Texas House of Representatives. |
|
|
Lalani |
|
|
|
______________________________ |
|
Speaker of the House |
|
|
I certify that H.R. No. 77 was adopted by the House on |
|
February 22, 2023, by a non-record vote. |
|
|
|
______________________________ |
|
Chief Clerk of the House |
|